Nilutamide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Nilutamide. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Adverse experiences | 86% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Metastatic Prostate Cancer Nilutamide Tablets are indicated for use in combination with surgical castration for the treatment of metastatic prostate cancer (Stage D2 ). For maximum benefit, treatment with Nilutamide Tablets must begin on the same day as or on the day after surgical castration.
Source: FDA labeling via NIH DailyMed (set d5740b8f…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.